English, Article edition: Evaluating Minimal Clinically Important Differences for the Acne-Specific Quality of Life Questionnaire Lori D. McLeod; Sheri E. Fehnel; Jane Brandman; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/119059
Physical Description
  • article
Language
  • English

Edition details

Title
  • Evaluating Minimal Clinically Important Differences for the Acne-Specific Quality of Life Questionnaire
Author
  • Lori D. McLeod
  • Sheri E. Fehnel
  • Jane Brandman
  • Tara Symonds
Physical Description
  • article
Notes
  • Background: The Acne-Specific Quality of Life Questionnaire (Acne-QoL) is a responsive, reliable and valid instrument developed to measure the impact of facial acne across four dimensions of patient QOL. Score changes on this instrument have been used to report statistically significant treatment advantages for a low-dose oral contraceptive (Estrostep(R)), containing norethisterone (norethindrone) acetate (NA) 1mg and ethinylestradiol (EE) [20, 30, 35mg] as compared with placebo in women with moderate acne vulgaris. However, the question remained if these statistically significant results were also clinically meaningful. Objectives: To evaluate the statistically significant Acne-QoL benefits observed with NA/​EE in terms of their clinical significance, and to compare the three different approaches for defining a minimal clinically important difference (MCID) for the Acne-QoL instrument. Methods: Since the optimum method for estimating MCIDs has yet to be established, three different published approaches for determining MCIDs were applied and compared using data from two randomised, double-blind, placebo- controlled studies of the efficacy of NA/​EE in the treatment of facial acne. Results: Although the approaches differed substantially, the resulting MCID estimates were comparable. Specifically, the MCID estimates ranged from 0.50-10.3 mean change per item, depending on the domain. The results showed that the statistically significant treatment advantages for NA/​EE were also clinically significant. Conclusion: When applied to the change scores present, the results showed that the statistically significant treatment advantages for NA/​EE were also clinically significant.
  • Acne, Pharmacoeconomics, Quality-of-life-rating-scales
  • RePEc:wkh:phecon:v:21:y:2003:i:15:p:1069-1079
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment